Safety and feasibility of neural transplantation in early to moderate Huntington's disease in the UK.

Lead Research Organisation: University of Cambridge
Department Name: Cambridge Centre for Brain Repair

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Publications

10 25 50
 
Description Citations in clinical guidelines and reviews
Geographic Reach Multiple continents/international 
Policy Influence Type Citation in clinical reviews
Impact we contribute to ongoing debate and updating of guidelines on ethical sourcing of human fetal tissues for research and clinical cell transplantation.
 
Description GTAC
Geographic Reach National 
Policy Influence Type Participation in a national consultation
Impact development of national ethical and regulatory guidelines
 
Description GTAC
Geographic Reach National 
Policy Influence Type Participation in advisory committee
Impact member of GTAC committee reviewing applications and developing policy on stem cell and gene therapy trials in the UK
 
Description MRC
Geographic Reach National 
Policy Influence Type Participation in advisory committee
Impact Targetted direction, policy and funding of UK stem cell research .
 
Description MRC Stem Cells
Geographic Reach National 
Policy Influence Type Participation in advisory committee
Impact I participate in the MRC UK Stem Cell Bank users group and contribute regularly to the policy discussions at head office on stem cell strategy and funding.
 
Description MRC stem cell
Geographic Reach National 
Policy Influence Type Participation in advisory committee
Impact I participate in the MRC Stem Cell Bank User's group and participate regularly in MRC stem cell policy and funding strategy meetings at Head Office.
 
Description MRC stem cells
Geographic Reach National 
Policy Influence Type Participation in advisory committee
Impact I participate in the MRC Stem Cell Bank User's group and participate regularly in MRC stem cell policy and funding strategy meetings at Head Office.
 
Description regular citations in clinical reviews and publications
Geographic Reach Multiple continents/international 
Policy Influence Type Citation in other policy documents
Impact influence on development of NECTAR and ASNTR guidelines
 
Description MRC Programme Grant
Amount £2,941,590 (GBP)
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 04/2010 
End 03/2013
 
Description PDS international collaboration
Amount £161,923 (GBP)
Funding ID J-0703 
Organisation Parkinson's UK 
Sector Charity/Non Profit
Country United Kingdom
Start 10/2007 
End 09/2009
 
Description REPLACES Restorative plasticity at corticostriatal excitatory synapses (4.2m euros across 12 participants)
Amount £873,507 (GBP)
Funding ID 222918 
Organisation European Commission 
Sector Public
Country European Union (EU)
Start 11/2008 
End 10/2012
 
Title mTOPs 
Description Validation of alternative protocols for consented collection of human fetal tissue 
Type Of Material Improvements to research infrastructure 
Year Produced 2009 
Provided To Others? Yes  
Impact Resolves the outstanding block on limited tissue availability to allow multiple international research and clinical trials to resume. 
 
Description 10-15 presentations to HDA and PDS patient groups 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Primary Audience Participants in your research and patient groups
Results and Impact 10-15 presentations to HDA and PDS patient groups. I present regular medical and lay seminars around the country and internationally. I am afraid I am unable to list all the individual presentations.

academic, medical and patient contacts
Year(s) Of Engagement Activity 2006,2007,2008,2009,2010
 
Description 10-15 presentations to HDA and PDS patient groups. 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Primary Audience Public/other audiences
Results and Impact I present regular medical and lay seminars around the country and internationally. I am afraid I am unable to list all the individual presentations.

various
Year(s) Of Engagement Activity 2006,2007,2008,2009,2010
 
Description 10-15 presentations to HDA and PDS patient groups. 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Primary Audience Participants in your research and patient groups
Results and Impact 10-15 presentations to HDA and PDS patient groups. I present regular medical and lay seminars around the country and internationally. I am afraid I am unable to list all the individual presentations.

various
Year(s) Of Engagement Activity 2006,2007,2008,2009,2010
 
Description 10-15 presentations to HDA and PDS patient groups. 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Primary Audience Public/other audiences
Results and Impact I present regular medical and lay seminars around the country and internationally. I am afraid I am unable to list all the individual presentations.

various
Year(s) Of Engagement Activity 2006,2007,2008,2009,2010
 
Description results included in multiple public and academic lectures and seminars 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Primary Audience Public/other audiences
Results and Impact results included in multiple public and academic lectures and seminars

various
Year(s) Of Engagement Activity 2006,2007,2008,2009,2010
 
Description results included in multiple public and academic lectures and seminars 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact results included in multiple public and academic lectures and seminars

various
Year(s) Of Engagement Activity 2006,2007,2008,2009,2010